Skip to main content

K2 PRINCIPAL FUND, L.P.

Position in NKTR — Nektar Therapeutics

CIK 1461790 TORONTO, A6

Position in NKTR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,522,961
New position
Shares Held
50,465
first reported quarter
Ownership
0.148%
of shares outstanding
% of Portfolio
0.94%
of 13F equity value
Holder Rank
#75
of 239 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Derivatives in NKTR

reported options exposure · as of Jun 30, 2026
CallValue
$1,745,250
CallShares
25,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

K2 PRINCIPAL FUND, L.P. holds $13,545,573 across 5 Biotechnology names. NKTR ranks #2 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NKTR
Nektar Therapeutics
This page
50,465 $3,522,961

All Filings in NKTR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,745,250 25,000
2026-06-30 $3,522,961 50,465